Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
The invention provides a series of compositions, methods, kits, articles and species associated primarily with the diagnosis and/or treatment of cell proliferation, specifically cancer. Cell proliferation associated with aberrant expression of MUC1 is particularly focused upon. Mechanisms associated with MUC1 cell proliferation are discussed.
1. A kit comprising:
a first article having a surface; and
a peptide sequence immobilized relative to or adapted to be immobilized relative to the surface, the peptide sequence comprising a portion of a cell surface receptor, in which an interchain binding region has been removed to the extent necessary to prevent self-aggregation of the peptide, wherein the peptide sequence interacts with an activating ligand to promote cell proliferation, wherein the primary sequence of said cell surface receptor consists of residues 1110-1154 of SEQ ID NO:10.
2. The kit as in claim 1 , further comprising a second article having a surface and the peptide sequence immobilized relative to or adapted to be immobilized relative to the surface of the second article.
3. The kit according to claim 1 , wherein the activating ligand is 14-3-3 protein, cathepsin D protein, or NM23 protein.
4. The kit according to claim 1 , wherein the peptide sequence comprises at least 12 contiguous amino acids from the sequence residues 1110-1154 of SEQ ID NO:10.
5. The kit according to claim 1 , wherein the peptide sequence comprises at least 12 contiguous amino acids from the sequence residues 1110-1142 of SEQ ID NO:10.
6. The kit according to claim 1 , wherein the article is a colloid particle.
7. The kit according to claim 6 , wherein the colloid is a gold colloid.
8. The kit according to claim 1 , wherein the peptide is adapted to be fastened to the article by an affinity tag attached to the peptide.
9. The kit according to claim 8 , wherein the affinity tag is polyamino acid tag, polyhistidine tag, GST tag, biotin, or thioredoxin.
10. The kit according to claim 8 , wherein the affinity tag is fastened to the C-terminus of the portion of the peptide.
11. The kit according to claim 10 , further comprising the activating ligand.
12. The kit according to claim 11 , wherein the activating ligand is NM23.